Frequency of Depression in Patients with Interstitial Lung Disease Presenting at Mardan Medical Complex

Muhammad Ullah Jan; Sajjad Ali Shah; Muhammad Farman; Muhammad Luqman; Amir Ali; Atif Rahim

doi:10.54112/bcsrj.v6i5.2357

Authors

Muhammad Ullah Jan Department of Pulmonology, Mardan Medical Complex, Mardan, Pakistan
Sajjad Ali Shah Department of Pulmonology, Mardan Medical Complex, Mardan, Pakistan
Muhammad Farman Department of Pulmonology, Mardan Medical Complex, Mardan, Pakistan
Muhammad Luqman Department of Pulmonology, Mardan Medical Complex, Mardan, Pakistan
Amir Ali Department of Pulmonology, Mardan Medical Complex, Mardan, Pakistan
Atif Rahim Department of Pulmonology, Mardan Medical Complex, Mardan, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i5.2357

Keywords:

Interstitial Lung Disease; Depression; Beck Depression Inventory; Frequency; Associated Factors

Abstract

Interstitial lung disease is a chronic respiratory condition associated with progressive functional limitation and impaired quality of life. These clinical consequences may increase the risk of depression, which often remains under-recognized in routine respiratory care. Objective: To determine the frequency of depression in patients with interstitial lung disease presenting at Mardan Medical Complex. Methods: A cross-sectional study was conducted on 100 patients with interstitial lung disease aged 18 to 70 years from 27 December 2024 to 27 April 2025 at the Department of Pulmonology, Mardan Medical Complex, Mardan. The diagnosis of interstitial lung disease was established based on clinical features and chest examination. Patients already on antidepressants and pregnant or lactating women were excluded. Depression was assessed using the Beck Depression Inventory, with a score exceeding 17 considered positive. Demographic and clinical data were recorded. Data were analysed using SPSS 27. Chi-square/Fisher exact tests were used for stratification, keeping the level of significance at 5%. Results: The mean age of the patients was 44.21±15.35 years, with the majority being male patients (62%), while females accounted for 38%. Hypertension was observed in 28% of patients, diabetes was present in 19% of patients, and 25% of patients were smokers in this study. The overall frequency of depression was 24% (n=24). Conclusion: The frequency of depression in interstitial lung disease patients in this study was 24%, underscoring the substantial psychological burden associated with this condition.

Downloads

Download data is not yet available.

0

References

1. Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. Lancet. 2022;400(10354):769-786.

2. Rivera-Ortega P, Molina-Molina M. Interstitial lung diseases in developing countries. Ann Glob Health. 2019;85(1):4.

3. Raghu G, Chen SY, Hou Q, Yeh WS, Collard HR. Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old. Eur Respir J. 2016;48(1):179-186.

4. Olson AL, Brown KK, Swigris JJ. Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis. Patient Relat Outcome Meas. 2016;7:29-35.

5. LeMoult J, Gotlib IH. Depression: A Cognitive Perspective. Clin Psychol Rev. 2019;69:51-66.

6. Park LT, Zarate CA Jr. Depression in the primary care setting. N Engl J Med. 2019;380(6):559-568.

7. Prigge R, Wild SH, Jackson CA. Depression, diabetes, comorbid depression and diabetes, and risk of all-cause and cause-specific mortality: a prospective cohort study. Diabetologia. 2022;65(9):1450-1460.

8. Wu CS, Hsu LY, Wang SH. Association of depression and diabetes complications and mortality: a population-based cohort study. Epidemiol Psychiatr Sci. 2020;29.

9. Lamers F, Jonkers CC, Bosma H, Chavannes NH, Knottnerus JA, van Eijk JT. Improving quality of life in depressed COPD patients: effectiveness of a minimal psychological intervention. COPD. 2010;7(5):315-322.

10. Ryerson CJ, Arean PA, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, et al. Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology. 2012;17(3):525-532.

11. Alharbi AR. Sleep disordered breathing in patients with interstitial lung disease: a systematic review. Pak J Chest Med. 2022;28(1):106-114. No DOI assigned.

12. Vastag Z, Tudorache E, Traila D, Fira-Mladinescu O, Marc MS, Oancea C, et al. Neurocognitive and neuropsychiatric implications of fibrosing interstitial lung diseases. Biomedicines. 2024;12(11):2572.

13. Tremblay Labrecque PF, Dion G, Saey D. Functional clinical impairments and frailty in interstitial lung disease patients. ERJ Open Res. 2022;8(4):00144-2022.

14. Ouyang X, Shen Q, Zhou S, Zhou P, Song M, Guo T, et al. Evaluating fatigue and excessive daytime sleepiness: a comparative analysis of prevalence and correlating factors in interstitial lung disease patients and healthy controls. Ann Med. 2024;56(1):2398729.